Medinotec Inc. (MDNC) Fair Value 2026

MDNC · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.2 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (17/100)

Quick Summary — As of 2026-08-27, Medinotec Inc. (MDNC) trades at $5.00, versus a $1.44 median fair value across its 8 active models — 71.1% below the current price. QOC: 8.2/10. Value Trap Risk: 17/100 (SAFE). 8/13 models active. Within that set, the Bayesian DCF component alone returns $1.45.

Key Facts

Ticker
MDNC
Price
$5.00
Quality Score
8.2/10
Value Trap Risk
17/100
Models Active
8/13
Last Updated
Strength: Quality Score of 8.2/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Medinotec Inc. (MDNC) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Medinotec Inc. (MDNC) appears overvalued as of : the median of 8 independent fair value estimates is $1.44, 71.1% below the current price of $5.00. Estimates range from $0.56 to $4.15. MDNC scores 8.2/10 on fundamental quality and 17/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. MDNC’s -71.1% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Medinotec Inc. Stock in 2026? →

What Fair Value Does Each Model Give MDNC?

8 Intrinsic Value Models vs. Current Price ($5.00)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $1.45 -71.0%
Ensemble · Low Conviction
 $1.37 -72.6%
Scenario · High Conviction
 $4.15 -17.0%
Intrinsic · High Conviction
 $0.77 -84.7%
Unlock the Full Matrix

Access 4 additional models including EROIC Spread, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is MDNC's Fair Value Range?

Spread across 8 independent models · $0.56 to $4.15

CirclFi's 8 active models place Medinotec Inc. (MDNC) between $0.56 and $4.15 per share, a spread of 249% of the median. The median of that range — $1.44 — is the fair value CirclFi publishes for MDNC, against a current price of $5.00.

Low · EROICHigh · First Chicago
$0.56median $1.44$4.15
Where the range comes from
Most bearish modelEROIC Spread$0.56
Most bullish modelFirst Chicago$4.15
Model agreement0 bullish · 8 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for MDNC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on MDNC, not a CirclFi price target. How each model works →

What Is Medinotec Inc. (MDNC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Medinotec Inc.'s intrinsic value is estimated at $1.44. Trading at its current price of $5.00, the valuation engine raises significant caution: 8 of 8 models flag downside risk, projecting a median implied return of -71.1%. Model dispersion is worth noting: First Chicago targets $4.15 (-17.0%), versus EROIC at $0.56 (-88.8%). This +71.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About MDNC?

8 of 13 models are currently active for MDNC. All 8 active models suggest the stock trades above fair value. Taken together, their median fair value for MDNC is $1.44 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $1.45 on its own, implying -71.0% downside from the current price. See which stocks rank higher →

How Does MDNC Rank in Medical Devices?

Among 157 Medical Devices stocks, MDNC ranks #23 by Quality of Company score. CirclFi's QOC score of 8.2/10 evaluates 32 fundamental signals. A score of 8.2 places MDNC in the top tier.

See all Most Undervalued Medical Devices Stocks →

Medinotec Inc.'s positioning within the Medical Devices segment means that FDA approval probability plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.

Is MDNC a Value Trap?

CirclFi's Value Trap algorithm assigns MDNC a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Medinotec Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Medinotec Inc. earns a quality score of 8.2/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +71.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MDNC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MDNC's 8 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Medinotec Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

USAQQHSLab, Inc.QOC 8.2BVSBioventus Inc.QOC 8.2HAEHaemonetics CorporationQOC 8.3ITGRInteger Holdings CorporationQOC 8.2ZBHZimmer Biomet Holdings, Inc.QOC 8.4VMDViemed Healthcare, Inc.QOC 8.1INGNInogen, Inc.QOC 6.7TLSITriSalus Life Sciences, Inc.QOC 5.7POSCPositron CorporationQOC 4.3IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: USAQ · BVS · HAE · ITGR · ZBH · VMD · INGN · TLSI · POSC · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to MDNC?

7 companies across all industries closest to MDNC’s Quality of Company score of 8.2/10.

STZConstellation Brands, Inc.QOC 8.2NTICNorthern Technologies International CorporationQOC 8.2HLTHilton Worldwide Holdings Inc.QOC 8.2NWBINorthwest Bancshares, Inc.QOC 8.2SFMSprouts Farmers Market, Inc.QOC 8.2CPFCentral Pacific Financial Corp.QOC 8.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: STZ · NTIC · HLT · NWBI · SFM · CPF · NVDA

Where Does MDNC Sit in CirclFi's Medical Devices Rankings?

MDNC is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Medinotec Inc.’s Valuation?

What is Medinotec Inc.'s intrinsic value in 2026?

CirclFi puts Medinotec Inc. (MDNC)'s intrinsic value at $1.44 — the median of 8 independent model estimates as of 2026-08-27, ranging from $0.56 to $4.15. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $1.45 on its own. The Quality of Company score is 8.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MDNC overvalued or undervalued right now?

At $5.00, 0 of 8 active models suggest MDNC may be undervalued, while 8 indicate potential overvaluation. The median of all 8 fair value estimates is $1.44, 71.1% below the current price of $5.00 — a consensus view that MDNC is overvalued. The assessment depends on which methodology best fits Medinotec Inc.'s business model in Medical Devices.

What does a Quality of Company score of 8.2 mean for MDNC?

Medinotec Inc.'s QOC of 8.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on MDNC?

CirclFi analyzes MDNC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on MDNC?

Of the 8 models currently active on MDNC, First Chicago is the most bullish at $4.15 per share, and EROIC Spread is the most bearish at $0.56. CirclFi's published fair value for MDNC is the median of that range, $1.44, not either extreme. The gap between the two ends equals 249% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is MDNC a value trap in 2026?

Medinotec Inc.'s Value Trap score is 17/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Medinotec Inc. (MDNC) has a median fair value of $1.44 — 71.1% below the current price of $5.00 — as of 2026-08-27.” Source: circlfi.com/stock/MDNC/ · Methodology
Primary sources for this MDNC valuation
  • Financial statements: Medinotec Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001931055) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MDNC as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on MDNC.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for MDNC Unlock All 8 — $39/mo